Sensex rises 308 points to 74,459 as IT, pharma lead; smallcaps fall
By Rohit SharmaMarkets Analyst, Peepals Business
Representative image: rupixen / Pixabay
The Sensex closed 308 points higher at 74,459.53 and the Nifty at 23,053.10 on 30 October 2026, led by IT and pharma, while smallcaps fell 1.85%.
What Happened
The Sensex index rose 308.49 points, or 0.42 per cent, to close at 74,459.53 on Friday, 30 October 2026, its second straight day of gains. The Nifty 50 added 116.35 points, or 0.51 per cent, to settle at 23,053.10, back above the 23,000 mark. Information technology and pharmaceutical shares led the move, while mid-sized and smaller companies fell sharply, so most shares on the market ended the day lower even as the headline indices rose.
Key Facts
- BSE Sensex: 74,459.53 at the close on 30 October, up 308.49 points (0.42 per cent) from Thursday's 74,151.
- NSE Nifty 50: 23,053.10, up 116.35 points (0.51 per cent).
- Nifty IT index: up a little more than 2 per cent, the best-performing sector of the day.
- Nifty Pharma index: up about 1.5 per cent.
- Nifty Midcap 100: down 0.93 per cent. Nifty Smallcap 100: down 1.85 per cent.
- Among the Nifty's top gainers: Trent, IndiGo (InterGlobe Aviation), Infosys, Sun Pharma and HCL Technologies.
- Among the main losers: Shriram Finance, Adani Ports, Mahindra & Mahindra, Adani Enterprises, Nestle India and State Bank of India.
- Brent crude stayed above $116 a barrel during the session, which market reports said limited the gains.
Why It Matters
Friday's session was a split one. The two indices that most people follow, the Sensex and the Nifty, are made up of the largest companies, and a handful of heavyweights rising is enough to lift them. Beneath that, the broader market had a weak day: the smallcap index lost almost 2 per cent and the midcap index almost 1 per cent. For a retail investor whose portfolio leans towards smaller companies, the day may have felt like a loss despite the green headline numbers.
The strength in IT shares is notable because the sector has been under pressure for weeks. Earlier this week, Indian IT stocks fell after news of an AI company's plans to list its shares revived worries that artificial intelligence tools could reduce demand for outsourced software services. On Friday, the sector moved the other way. Market reports linked part of the buying to investors shifting money into Indian IT names during a broader global sell-off in technology shares, after big US companies, including Google's owner Alphabet, saw steep falls this week. Infosys was among the strongest Nifty gainers. The company cut its revenue growth outlook for the year earlier this month, so the rise suggests buyers saw value after the earlier decline.
Pharma shares also gained, with Sun Pharma among the leaders, as several drug makers reported quarterly results. Trent, the Tata group retailer that runs Westside and Zudio, extended its rally after reporting a 25 per cent rise in quarterly profit this week. IndiGo's shares rose even though the airline reported a quarterly loss of Rs 1,879 crore and its chief executive said fare increases could not be avoided because of high fuel costs.
On the losing side, the list was dominated by financial and industrial names. Shriram Finance, which has been weak since its results despite a jump in profit, fell again. State Bank of India, the country's largest lender, slipped along with Adani group companies and Mahindra & Mahindra.
Oil remains the biggest outside worry. India imports most of the crude oil it uses, and Brent above $116 a barrel raises costs for airlines, paint makers, chemical companies and oil marketing firms, and adds to inflation. Brent's climb above $110 earlier this month coincided with several losing sessions for the Sensex.
| Index or sector | Close or move on 30 October 2026 |
|---|---|
| BSE Sensex | 74,459.53, up 308.49 points (0.42%) |
| NSE Nifty 50 | 23,053.10, up 116.35 points (0.51%) |
| Nifty IT | up a little over 2% |
| Nifty Midcap 100 | down 0.93% |
| Nifty Smallcap 100 | down 1.85% |
Impact
Short-term: The Nifty's return above 23,000 gives the market a better end to the week, but the fall in midcap and smallcap shares shows that buyers were selective. Next week, attention turns to more quarterly results, crude oil prices and global technology shares.
Long-term: A rally led by a few large sectors is less durable than one in which most shares rise together. Whether IT shares can keep recovering will depend on how clients' spending on technology holds up as AI tools spread, and on the companies' own guidance in the coming quarters.
Who is affected: Investors in IT and pharma shares and in large-company index funds gained on the day. Holders of midcap and smallcap shares and funds saw losses. Companies that depend on fuel, such as airlines and transport firms, remain sensitive to oil prices.
Key Takeaway
The Sensex rose 308 points to 74,459.53 and the Nifty closed at 23,053.10 on 30 October 2026 as IT and pharma shares rallied, while the Nifty Smallcap 100 fell 1.85 per cent.
Questions and Answers
Where did the Sensex index close on 30 October 2026?
The BSE Sensex closed at 74,459.53, up 308.49 points or 0.42 per cent, on Friday, 30 October 2026. It was the index's second consecutive day of gains.
Which sectors drove the market higher?
IT shares led, with the Nifty IT index rising a little over 2 per cent. Pharma shares were next, with the Nifty Pharma index up about 1.5 per cent. Infosys, HCL Technologies and Sun Pharma were among the gainers.
Why did smallcap shares fall when the Sensex rose?
The Sensex and Nifty track the largest companies, and gains in a few heavyweight sectors lifted them. Smaller companies saw selling, and the Nifty Smallcap 100 fell 1.85 per cent while the Nifty Midcap 100 lost 0.93 per cent.
Is this a signal to buy shares?
No single day's move is a buy or sell signal, and this report is not investment advice. Market direction will depend on factors such as oil prices, company results and global technology shares.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
By Rohit Sharma, Markets AnalystCovers Markets Watch and more for Peepals Business. All stories by Rohit Sharma
Get the day's stories in your inbox
Peepals Weekly: the week decoded, free. One email a week, unsubscribe in one click.
Rohit Sharma is a pen name of the Peepals Global Editorial Team, which researches, fact-checks and publishes every story. The portrait is an illustration.
